Finoriq research workspace

Bausch Health Companies Inc. (BHC) Insider Transactions & Form 4 Activity

Track insider acquisitions, dispositions, options, RSUs, and Form 4 activity for Bausch Health Companies Inc. (BHC).

Company Snapshot

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Company

Bausch Health Companies Inc. (BHC)

Ticker

BHC

Market Cap

$1.8B

Latest Price

$4.71

Industry

Biotech & Pharma

Open company research

Bausch Health Companies Inc. (BHC) Recent Insider Transactions

Recent market insider transaction records indexed for Bausch Health Companies Inc. (BHC).

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.